🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
90 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

500 mcg (417% DV)
📊 4.2× RDA — above typical dose 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.5mg
100 mcg (83% DV)
✅ Within RDA (0.8× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.1mg

Other Ingredients

extra virgin Olive Oil Medium Chain Triglyceride Oil Gelatin Glycerin purified Water Carob color

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: For general health: take one capsule per day. For heart and arterial health: take two capsules per day. Best if consumed with a meal.

⚠️ Warnings & Precautions

If you are pregnant, nursing, or taking any prescription medication (especially anticoagulants like Warfarin/Coumadin), talk to your doctor before use.

Keep out of reach of children.

May contain ingredients sourced from nightshade.

🧪 Formulation Notes

K2 Complex There are several forms of Vitamin K2. They perform different functions. MK-7 and MK-4 are two major forms of K2. MK-4 is the primary Vitamin K2 present in the brain.

Preliminary research suggests that Vitamin K2 is not only critical for bone health, but may also help promote a healthy brain and arteries.

Does Not Contain: Dairy, eggs, corn, fish, shellfish, tree nuts, peanuts, wheat/gluten, soy, sugar, GMO, yeast, artificial colors or flavors.

Soy free.

Major allergen free.

MK-4 + MK-7

Healthy bones and arteries Promotes calcium transport into bones Helps promote vascular health

Source: Encapsulated, packaged, and third-party tested in USA with domestic and international ingredients.

Additional Information

Store at room temperature.

Product Details

UPC / SKU 7 94504 98465 1
DSLD Entry Date 2021-06-23
Product Type Vitamin
Form Capsule
Brand InnovixLabs
DSLD ID 248215
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →